Ads
related to: biotech- Careers
Join our Mission to Improve
the Lives of Patients.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Sign Up
Sign Up for Updates, News
and Much More.
- Careers
Search results
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks via Yahoo Finance· 3 days agoThe iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded...
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks via Yahoo Finance· 2 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
Benzinga via Yahoo Finance· 3 days agoOn Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2...
MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such...
Morningstar· 23 hours agoMAIA Biotechnology shares rose after the company said telomere targeting functionality, used by its THIO candidate, was shown to be viable by the Food and Drug Administration's ...
CollPlant prints commercial-size regenerative breast implants By Investing.com
Investing.com· 17 hours agoCollPlant Biotechnologies (NASDAQ:CLGN), an innovator in regenerative and aesthetic medicine, has...
CollPlant Biotechnologies First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 3 days agoCollPlant Biotechnologies (NASDAQ:CLGN) First Quarter 2024 Results Key Financial Results Revenue:...
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Zacks via Yahoo Finance· 4 days agoThe First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively...
GSK acquires Elsie to unlock oligonucleotide therapeutics
Pharmaceutical Technology via Yahoo Finance· 1 day agoGSK has acquired Elsie Biotechnologies for $50m to unlock the potential of oligonucleotide...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Crossmark Global Holdings Inc.
ETF DAILY NEWS· 10 hours ago(NASDAQ:BIIB – Free Report) by 19.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,527 shares of the biotechnology company’s stock after ...
National Security Commission on Emerging Biotechnology Announces Introduction of Agricultural Bills
The National Law Review· 4 days agoOn May 23, 2024, the National Security Commission on Emerging Biotechnology (NSCEB) issued a press...